dalcetrapib: Clinical Trials

1 trial of dalcetrapib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow dalcetrapib: new trials by email Literature Review of dalcetrapib trials Research Report on dalcetrapib

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Dalcetrapib, Placebo - Cardiovascular Disease
Phase 3TerminatedHoffmann-La Roche9362010-01-012020-03-24

Conditions studied

Cardiovascular Diseases (1)

Sponsors

Hoffmann-La Roche (1)

Countries

Canada (1)  ·  Germany (1)  ·  Poland (1)  ·  Switzerland (1)  ·  United States (1)

Results publications

PMID 25583994, PMID 27418594